Paper34412685
Novel CAR T therapy is a ray of hope in the treatment of seriously ill AML patients.
Marofi F and 15 others. Stem Cell Res Ther, 2021. Cited by 75 papers, by iCite.
Cite this record
ConductScience Library. Novel CAR T therapy is a ray of hope in the treatment of seriously ill AML patients. Papers, record 34412685. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34412685
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Leukemia, Myeloid, Acute | Major topic |
| Receptors, Chimeric Antigen | Major topic |
| Humans | |
| Immunotherapy | |
| Immunotherapy, Adoptive | |
| T-Lymphocytes |
Source PubMed
References192
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11222367 | A Fas-based suicide switch in human T cells for the treatment of graft-versus-host disease. | Blood | 2001 | https://conductscience.org/library/papers/11222367 | PubMed |
| 2 | 29385370 | Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia. | N Engl J Med | 2018 | https://conductscience.org/library/papers/29385370 | PubMed |
| 3 | 15931392 | Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells. | J Clin Invest | 2005 | https://conductscience.org/library/papers/15931392 | PubMed |
| 4 | 25939063 | 4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors. | Nat Med | 2015 | https://conductscience.org/library/papers/25939063 | PubMed |
| 5 | 30275568 | Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell. | Nat Med | 2018 | https://conductscience.org/library/papers/30275568 | PubMed |
| 6 | 11021753 | The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells. | Leukemia | 2000 | https://conductscience.org/library/papers/11021753 | PubMed |
| 7 | 24876563 | Current concepts in the diagnosis and management of cytokine release syndrome. | Blood | 2014 | https://conductscience.org/library/papers/24876563 | PubMed |
| 8 | 3960109 | Retrovirus-mediated transfer and expression of drug resistance genes in human haematopoietic progenitor cells. | Nature | 1986 | https://conductscience.org/library/papers/3960109 | PubMed |
| 9 | 17108138 | CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in vivo persistence and antitumor efficacy of adoptively transferred T cells. | Cancer Res | 2006 | https://conductscience.org/library/papers/17108138 | PubMed |
| 10 | 17227830 | CD33 expression and P-glycoprotein-mediated drug efflux inversely correlate and predict clinical outcome in patients with acute myeloid leukemia treated with gemtuzumab ozogamicin monotherapy. | Blood | 2007 | https://conductscience.org/library/papers/17227830 | PubMed |
| 11 | 29856956 | Genetic Inactivation of CD33 in Hematopoietic Stem Cells to Enable CAR T Cell Immunotherapy for Acute Myeloid Leukemia. | Cell | 2018 | https://conductscience.org/library/papers/29856956 | PubMed |
| 12 | 7053567 | Liposomes as gene carriers: efficient transformation of mouse L cells by thymidine kinase gene. | Science | 1982 | https://conductscience.org/library/papers/7053567 | PubMed |
| 13 | 22553251 | Decade-long safety and function of retroviral-modified chimeric antigen receptor T cells. | Sci Transl Med | 2012 | https://conductscience.org/library/papers/22553251 | PubMed |
| 14 | 28666104 | Hematopoietic stem cell transplantation for acute myeloid leukemia: A review. | Hematol Oncol Stem Cell Ther | 2017 | https://conductscience.org/library/papers/28666104 | PubMed |
| 15 | 17609428 | The novel AML stem cell associated antigen CLL-1 aids in discrimination between normal and leukemic stem cells. | Blood | 2007 | https://conductscience.org/library/papers/17609428 | PubMed |
| 16 | 24777247 | T cells expressing chimeric antigen receptors can cause anaphylaxis in humans. | Cancer Immunol Res | 2013 | https://conductscience.org/library/papers/24777247 | PubMed |
| 17 | 31723825 | CAR T Cell Toxicity: Current Management and Future Directions. | Hemasphere | 2019 | https://conductscience.org/library/papers/31723825 | PubMed |
| 18 | 28029927 | Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy. | N Engl J Med | 2016 | https://conductscience.org/library/papers/28029927 | PubMed |
| 19 | 23831595 | Persistence and efficacy of second generation CAR T cell against the LeY antigen in acute myeloid leukemia. | Mol Ther | 2013 | https://conductscience.org/library/papers/23831595 | PubMed |
| 20 | 30809033 | Early and late hematologic toxicity following CD19 CAR-T cells. | Bone Marrow Transplant | 2019 | https://conductscience.org/library/papers/30809033 | PubMed |
Cited by46
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 75 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42767771 | Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of acute leukemia, version 2.0. | J Immunother Cancer | 2026 | https://conductscience.org/library/papers/42767771 | PubMed |
| 42592083 | Tunable universal OR-gated CAR T cells for AML. | iScience | 2026 | https://conductscience.org/library/papers/42592083 | PubMed |
| 42200022 | Efficacy and safety of FLT3 inhibitors for acute myeloid leukemia: a network meta-analysis. | Front Oncol | 2026 | https://conductscience.org/library/papers/42200022 | PubMed |
| 41131610 | CAR-T and CAR-NK cell therapies in AML: breaking barriers and charting the future. | J Transl Med | 2025 | https://conductscience.org/library/papers/41131610 | PubMed |
| 40779041 | Exosome-Based Therapies in Dermatology. | Aesthetic Plast Surg | 2025 | https://conductscience.org/library/papers/40779041 | PubMed |
| 40649828 | Targets for CAR Therapy in Multiple Myeloma. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40649828 | PubMed |
| 40583406 | NKT cells-a generalist in disease treatment and a new key to unlock immunotherapy. | Immunotherapy | 2025 | https://conductscience.org/library/papers/40583406 | PubMed |
| 40564892 | The Problem of Molecular Target Choice for CAR-T Cells in Acute Myeloid Leukemia Therapy. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40564892 | PubMed |
| 40557469 | CD38-Targeting Peptide Vaccine Ameliorates Aging-Associated Phenotypes in Mice. | Aging Cell | 2025 | https://conductscience.org/library/papers/40557469 | PubMed |
| 40425009 | CD97-directed CAR-T cells with enhanced persistence eradicate acute myeloid leukemia in diverse xenograft models. | Cell Rep Med | 2025 | https://conductscience.org/library/papers/40425009 | PubMed |
| 40144774 | Recent advances of CAR-T cells in acute myeloid leukemia. | Ther Adv Hematol | 2025 | https://conductscience.org/library/papers/40144774 | PubMed |
| 39877157 | Stem cell status and prognostic applications of cuproptosis-associated lncRNAs in acute myeloid leukemia. | Front Cell Dev Biol | 2024 | https://conductscience.org/library/papers/39877157 | PubMed |
| 39833547 | CRISPR knock-in of a chimeric antigen receptor into GAPDH 3'UTR locus generates potent B7H3-specific NK-92MI cells. | Cancer Gene Ther | 2025 | https://conductscience.org/library/papers/39833547 | PubMed |
| 38712978 | Recent advances in CAR-T cell therapy for acute myeloid leukaemia. | J Cell Mol Med | 2024 | https://conductscience.org/library/papers/38712978 | PubMed |
| 38541635 | Recent Advances towards the Understanding of Secondary Acute Myeloid Leukemia Progression. | Life (Basel) | 2024 | https://conductscience.org/library/papers/38541635 | PubMed |
| 38213150 | Advanced Strategies of CAR-T Cell Therapy in Solid Tumors and Hematological Malignancies. | Recent Pat Anticancer Drug Discov | 2024 | https://conductscience.org/library/papers/38213150 | PubMed |
| 38151649 | Gastric cancer and mesenchymal stem cell-derived exosomes: from pro-tumorigenic effects to anti-cancer vehicles. | Arch Pharm Res | 2024 | https://conductscience.org/library/papers/38151649 | PubMed |
| 38090582 | Broadening the horizon: potential applications of CAR-T cells beyond current indications. | Front Immunol | 2023 | https://conductscience.org/library/papers/38090582 | PubMed |
| 38048594 | A dual-receptor T-cell platform with Ab-TCR and costimulatory receptor achieves specificity and potency against AML. | Blood | 2024 | https://conductscience.org/library/papers/38048594 | PubMed |
| 38021600 | Clinical Trials on Cellular Therapy for Children and Adolescents With Cancer: A 15-Year Trend in the United States. | Cureus | 2023 | https://conductscience.org/library/papers/38021600 | PubMed |
Genes88
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34412685
GET https://conductscience.org/api/papers/v1/34412685/references?page=2